L&C BIO Co.,LTD (KOSDAQ:290650)
69,700
+5,800 (9.08%)
Apr 10, 2026, 3:30 PM KST
265.88% (1Y)
| Market Cap | 1.59T +218.1% |
| Revenue (ttm) | 85.48B +18.7% |
| Net Income | -138.17B |
| EPS | -5,819.37 |
| Shares Out | 24.85M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 50.00 (0.08%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 280,062 |
| Average Volume | 197,662 |
| Open | 64,800 |
| Previous Close | 63,900 |
| Day's Range | 63,800 - 70,800 |
| 52-Week Range | 18,570 - 125,000 |
| Beta | 1.61 |
| RSI | 46.02 |
| Earnings Date | Mar 24, 2026 |